Toward earlier diagnosis of amyotrophic lateral sclerosis: Revised criteria

Neurology

Volumn 50, Issue 3, 1998, Pages 768-772

  Ross, Mark A ^a   Miller, R G ^b   Berchert, L ^b   Parry, G ^b   Barohn, R J ^b   Armon, C ^b   Bryan, W W ^b   Petajan, J ^b   Stromatt, S ^b   Goodpasture, J ^b   McGuire, D ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ELECTROMYOGRAM; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0031895695     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.3.768     Document Type: Article

References (15)

1. World Federation of Neurology Research Group on Neuromuscular Diseases. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl):96-107.
2. Bensimon G, Lacomblez L, Meininger V, et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-637.
3. Lacomblez L, Bensimon G, Leigh PN, et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347:1425-1431.
4. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymmidine (AZT) in the treatment of patients with aids and aids-related complex, a double-blind, placebo-controlled trial. N Engl J Med 1987;317:185-191.
5. Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104.
6. Miller RG, Petajan J, Bryan WW, et al. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. Ann Neurol 1996;39: 256-260.
7. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. The Practitioner 1964;192:540-542.
8. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: electrodiagnostic features. Muscle Nerve 1994;17: 198-205.
9. Caroscio JT, Mulvihill MN, Sterling R, et al. Amyotrophic lateral sclerosis - its natural history. Neurol Clin 1987;5:1-9.
10. Mulder DW. Motor neuron disease. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, ed 2, Vol. 2. Philadelphia, PA: WB Saunders, 1984:1525-1536.
11. ALS CNTF Treatment Study Group. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 1996;46:1244-1249.
12. Chaudhuri KR, Crump SJ, Al-Sarraj S, et al. The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinico-pathological study. J Neurol Sci 1995; 129(Suppl): 11-12.
13. Lambert EH. Electromyography in amyotrophic lateral sclerosis. In: Norris FJ, Kurland LT, eds. Motor neuron disease. New York: Grune and Stratton, 1969:135-153.
14. Daube J. Electrophysiologic studies in the diagnosis and prognosis of motor neuron diseases. Neurol Clin 1985;3:473-491.
15. Armon C. Motor neuron disease. In: Gorelick PB, Alter M, eds. Handbook of neuroepidemiology. New York: Marcel Dekker, 1994:407-454.